Gilhus NE, Maniaol AH(2025) Myasthenia gravis - new, improved treatment Tidsskr Nor Laegeforen, 145(15) DOI 10.4045/tidsskr.25.0582, PubMed 41410951
Olsen CG, Malmberg VN, Fahlström M, Alstadhaug KB, Bjørnå IK, Braathen GJ, Bråthen G, Demic N, Hallerstig E, Hogenesch I, Horn MA, Kampman MT, Kleveland G, Ljøstad U, Maniaol A, Morsund ÅH, Nakken O, Schlüter K, Schuler S, Seim E, Flemmen HØ, Tysnes OB, Holmøy T, Høyer H(2024) Amyotrophic lateral sclerosis caused by the C9orf72 expansion in Norway - prevalence, ancestry, clinical characteristics and sociodemographic status Amyotroph Lateral Scler Frontotemporal Degener, 26(1-2), 132-140 DOI 10.1080/21678421.2024.2405118, PubMed 39316038
Howard JF, Bresch S, Farmakidis C, Freimer M, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski HJ, Maniaol A, Mantegazza R, Masuda M, Nowak RJ, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss MD, Zajda M, Bloemers J, Boroojerdi B, Brock M, de la Borderie G, Duda PWet al.(2024) Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study Ther Adv Neurol Disord, 17, 17562864241243186 DOI 10.1177/17562864241243186, PubMed 38638673
